Alkermes plc (ALKS) vs Indivior Pharmaceuticals Inc. (INDV)
- Alkermes plc ALKS 41.22 +2.79%
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
Alkermes plc and Indivior Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc is the larger, with a market value of $6.7B against $4.0B — 1.7× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 11.2× against 102×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 13.5% against 10.8%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs 3.97%) and the higher return on invested capital (460.5% vs 2.76%). Across the 19 metrics below, Indivior Pharmaceuticals Inc. leads on 13 and Alkermes plc on 6.
Valuation
Profitability
| Metric | ALKS | INDV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 84.56% | 81.97% | 53.94% |
| Operating margin | 7.03% | 31.56% | 0.00% |
| Net margin | 3.97% | 26.75% | 0.00% |
| Free cash flow margin | 13.35% | (8.34%) | 0.00% |
| Return on equity | 3.85% | (153.12%) | (0.40%) |
| Return on assets | 1.99% | 26.52% | (3.32%) |
| Return on invested capital | 2.76% | 460.53% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack